• Users Online: 37496
  • Home
  • Print this page
  • Email this page

    Article Cited by others

GUEST EDITORIAL

Use of intravitreal anti-VEGF: Retinopathy of prematurity surgeons' in Hamlet's dilemma?

Azad Rajvardhan

Year : 2011| Volume: 59| Issue : 6 | Page no: 421-422

   This article has been cited by
 
1 Omega-3/Omega-6 Long-Chain Fatty Acid Imbalance in Phase I Retinopathy of Prematurity
Zhongjie Fu, Wenjun Yan, Chuck T. Chen, Anders K. Nilsson, Edward Bull, William Allen, Jay Yang, Minji Ko, John Paul SanGiovanni, James D. Akula, Saswata Talukdar, Ann Hellström, Lois E. H. Smith
Nutrients. 2022; 14(7): 1333
[Pubmed]  [Google Scholar] [DOI]
2 Serious adverse events and visual outcomes of rescue therapy using adjunct bevacizumab to laser and surgery for retinopathy of prematurity. The Indian Twin Cities Retinopathy of Prematurity Screening database Report number 5
S. Jalali,D. Balakrishnan,Z. Zeynalova,T. R. Padhi,P. K. Rani
Archives of Disease in Childhood - Fetal and Neonatal Edition. 2013; 98(4): F327
[Pubmed]  [Google Scholar] [DOI]
3 Unusual Adverse Choroidal Reaction to Intravitreal Bevacizumab in Aggressive Posterior Retinopathy of Prematurity: The Indian Twin Cities ROP Screening (ITCROPS) Data Base Report Number 7*
Jay Chhablani,Padmaja Kumari Rani,Divya Balakrishnan,Subhadra Jalali
Seminars in Ophthalmology. 2013; : 1
[Pubmed]  [Google Scholar] [DOI]

 

Read this article